211 related articles for article (PubMed ID: 29666116)
21. Pathogenesis of follicular lymphoma: genetics to the microenvironment to clinical translation.
Kumar E; Pickard L; Okosun J
Br J Haematol; 2021 Sep; 194(5):810-821. PubMed ID: 33694181
[TBL] [Abstract][Full Text] [Related]
22. Molecular insights into the immunopathogenesis of follicular lymphoma.
Stamatopoulos K; Kosmas C; Belessi C; Stavroyianni N; Kyriazopoulos P; Papadaki T
Immunol Today; 2000 Jun; 21(6):298-305. PubMed ID: 10825742
[TBL] [Abstract][Full Text] [Related]
23. T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling.
Josefsson SE; Huse K; Kolstad A; Beiske K; Pende D; Steen CB; Inderberg EM; Lingjærde OC; Østenstad B; Smeland EB; Levy R; Irish JM; Myklebust JH
Clin Cancer Res; 2018 Feb; 24(4):870-881. PubMed ID: 29217528
[No Abstract] [Full Text] [Related]
24. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F
Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470
[TBL] [Abstract][Full Text] [Related]
25. Follicular lymphoma evolves with a surmountable dependency on acquired glycosylation motifs in the B-cell receptor.
Haebe S; Day G; Czerwinski DK; Sathe A; Grimes SM; Chen T; Long SR; Martin B; Ozawa MG; Ji HP; Shree T; Levy R
Blood; 2023 Dec; 142(26):2296-2304. PubMed ID: 37683139
[TBL] [Abstract][Full Text] [Related]
26. Genetics of follicular lymphoma transformation.
Pasqualucci L; Khiabanian H; Fangazio M; Vasishtha M; Messina M; Holmes AB; Ouillette P; Trifonov V; Rossi D; Tabbò F; Ponzoni M; Chadburn A; Murty VV; Bhagat G; Gaidano G; Inghirami G; Malek SN; Rabadan R; Dalla-Favera R
Cell Rep; 2014 Jan; 6(1):130-40. PubMed ID: 24388756
[TBL] [Abstract][Full Text] [Related]
27. Recent landmark studies in follicular lymphoma.
Sorigue M; Sancho JM
Blood Rev; 2019 May; 35():68-80. PubMed ID: 30928169
[TBL] [Abstract][Full Text] [Related]
28. Follicular lymphoma grade 3: review and updates.
Vaidyanathan G; Czuczman MS
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):431-5. PubMed ID: 25066038
[TBL] [Abstract][Full Text] [Related]
29. Cell migration patterns and ongoing somatic mutations in the progression of follicular lymphoma.
Adam P; Schoof J; Hartmann M; Schwarz S; Puppe B; Ott M; Rosenwald A; Ott G; Muller-Hermelink HK
Cytogenet Genome Res; 2007; 118(2-4):328-36. PubMed ID: 18000387
[TBL] [Abstract][Full Text] [Related]
30. The Biological Basis of Histologic Transformation.
Kumar EA; Okosun J; Fitzgibbon J
Hematol Oncol Clin North Am; 2020 Aug; 34(4):771-784. PubMed ID: 32586580
[TBL] [Abstract][Full Text] [Related]
31. Cytokine-related genes play critical roles in extrafollicular growth of follicular lymphoma cells.
Yoshida N; Miyoshi H; Arakawa F; Nakashima K; Kawamoto K; Seto M; Ohshima K
Hematol Oncol; 2020 Dec; 38(5):673-679. PubMed ID: 32835439
[TBL] [Abstract][Full Text] [Related]
32. Clinical and Biological Prognostic Factors in Follicular Lymphoma.
Patel AA; Smith SM
Hematol Oncol Clin North Am; 2020 Aug; 34(4):647-662. PubMed ID: 32586571
[TBL] [Abstract][Full Text] [Related]
33. Follicular lymphoma and the immune system: from pathogenesis to antibody therapy.
Stevenson FK; Stevenson GT
Blood; 2012 Apr; 119(16):3659-67. PubMed ID: 22337721
[TBL] [Abstract][Full Text] [Related]
34. Single-cell RNA-Seq of follicular lymphoma reveals malignant B-cell types and coexpression of T-cell immune checkpoints.
Andor N; Simonds EF; Czerwinski DK; Chen J; Grimes SM; Wood-Bouwens C; Zheng GXY; Kubit MA; Greer S; Weiss WA; Levy R; Ji HP
Blood; 2019 Mar; 133(10):1119-1129. PubMed ID: 30591526
[TBL] [Abstract][Full Text] [Related]
35. Pathology of follicular lymphoma.
Takata K; Miyata-Takata T; Sato Y; Yoshino T
J Clin Exp Hematop; 2014; 54(1):3-9. PubMed ID: 24942941
[TBL] [Abstract][Full Text] [Related]
36. Chromatin modifying gene mutations in follicular lymphoma.
Green MR
Blood; 2018 Feb; 131(6):595-604. PubMed ID: 29158360
[TBL] [Abstract][Full Text] [Related]
37. Somatic mutation of the 5' noncoding region of the BCL-6 gene is associated with intraclonal diversity and clonal selection in histological transformation of follicular lymphoma.
Szereday Z; Csernus B; Nagy M; László T; Warnke RA; Matolcsy A
Am J Pathol; 2000 Mar; 156(3):1017-24. PubMed ID: 10702417
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and management of follicular lymphoma: A comprehensive review.
Dada R
Eur J Haematol; 2019 Sep; 103(3):152-163. PubMed ID: 31270855
[TBL] [Abstract][Full Text] [Related]
39. The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era.
Blaker YN; Spetalen S; Brodtkorb M; Lingjaerde OC; Beiske K; Østenstad B; Sander B; Wahlin BE; Melen CM; Myklebust JH; Holte H; Delabie J; Smeland EB
Br J Haematol; 2016 Oct; 175(1):102-14. PubMed ID: 27341313
[TBL] [Abstract][Full Text] [Related]
40. IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution.
Odabashian M; Carlotti E; Araf S; Okosun J; Spada F; Gribben JG; Forconi F; Stevenson FK; Calaminici M; Krysov S
Blood; 2020 Mar; 135(11):834-844. PubMed ID: 31932843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
